Our Network of Board-Certified Providers
Connect with experienced, US-licensed physicians specializing in metabolic health and GLP-1 therapy. All providers are board-certified and committed to evidence-based care.
If you live in the Florida area of New Orleans, Louisiana, getting FDA-approved GLP-1 receptor agonist medications has never been simpler. Our straightforward telehealth platform removes every barrier — no confusing paperwork, no lengthy wait times, no complicated insurance pre-authorization for most patients in Orleans County. Just three clear steps from assessment to medication at your door.
GLP-1 medications including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are prescribed by LA-licensed doctors through a simple, jargon-free process designed specifically for New Orleans residents who want effective care without the complexity.[1][2]
Medically reviewed by
Dr. Sarah Mitchell, MD, ABOM
Board-Certified in Obesity Medicine • Last reviewed: June 6, 2026
Semaglutide is marketed as Ozempic for type 2 diabetes management and Wegovy for chronic weight loss in adults with obesity or overweight. Licensed physicians design individualized titration schedules — escalating dose over 16–20 weeks — to maximize weight reduction while minimizing gastrointestinal side effects.
Tirzepatide simultaneously activates GLP-1 and GIP receptors, producing additive metabolic effects beyond those of single-agonist GLP-1 therapies. Mounjaro (type 2 diabetes) and Zepbound (obesity) require physician expertise in dual-receptor pharmacology and careful patient selection to optimize outcomes.
Landmark randomized controlled trials in the New England Journal of Medicine establish the efficacy profile of FDA-approved GLP-1 medications available to Florida, New Orleans residents:
Telehealth prescribing of GLP-1 receptor agonists in Louisiana is conducted by board-certified, LA-licensed physicians through HIPAA-compliant platforms. GLP-1 medications are not DEA-scheduled controlled substances and may be prescribed via telehealth after a valid clinical evaluation.
Getting GLP-1 from Florida is as simple as it gets — three clear steps, no complications, no wasted time. Everything happens from your home in New Orleans with no trips to clinics or pharmacies required.
Answer a short, straightforward health questionnaire from your home in Florida. Simple language, no medical jargon. Cover your basic health history, current medications, weight, and goals. The whole thing takes 2-3 minutes. That is it for step one.
A LA-licensed physician reviews your answers and conducts a simple telehealth consultation. They explain your options clearly, answer any questions, and issue your prescription without unnecessary complexity. Most patients find this the easiest medical consultation they have ever had.
Your GLP-1 medication ships directly to your Florida address from a licensed US pharmacy. Most patients in New Orleans receive their medication within 3-5 business days. No pharmacy lines, no picking up packages — just open the door and begin your treatment.
Our easy telehealth platform serves all neighborhoods in New Orleans and surrounding areas with the same straightforward process.
Simple GLP-1 telehealth access across every neighborhood in New Orleans, LA — no complications anywhere.
Also offering the same easy, no-complication GLP-1 access in cities near New Orleans.
Easy, no-complication GLP-1 telehealth available in the largest cities across Louisiana.
Licensed GLP-1 telehealth physicians serve neighborhoods across all major US cities, providing the same clinical-grade care available at specialty obesity medicine centers.
Local weight loss and GLP-1 providers serving the Florida, New Orleans area, based on Google Business listings.
631 St Charles Ave Suite 2A
5/5 ★ (22 reviews)
Marrero, LA
5/5 ★ (1 reviews)
3838 N Causeway Blvd %232020, Metairie, LA 70002
5/5 ★ (1 reviews)
Connect with experienced, US-licensed physicians specializing in metabolic health and GLP-1 therapy. All providers are board-certified and committed to evidence-based care.
Extremely simple. Residents of Florida and greater New Orleans, Louisiana complete just three steps: a 2-3 minute health questionnaire, a short telehealth consultation with a LA-licensed physician, and then wait for home delivery. That is the entire process from start to finish.
Very little. Patients in Florida and throughout New Orleans complete a straightforward digital health questionnaire — no complicated forms, no faxing documents to clinics. The entire process is managed online through a simple, intuitive platform.
Not at all. Everything on our New Orleans platform is written in plain language. Your physician consultation is a friendly, jargon-free conversation. We make GLP-1 access simple for everyone, regardless of their medical background.
Yes, completely straightforward. Orleans County residents can access all FDA-approved GLP-1 medications — semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), and liraglutide (Saxenda) — through a simple three-step online process with no in-person visits required.
Simplicity and safety go hand in hand on our platform. All prescriptions are issued by board-certified, LA-licensed physicians through HIPAA-compliant telehealth platforms. We have made the process simple without cutting any corners on medical quality.
Black Box Warning: In rodent studies, semaglutide and tirzepatide caused thyroid C-cell tumors. It is unknown whether GLP-1 receptor agonists cause thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans. These medications are contraindicated in patients with a personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Common side effects may include nausea, vomiting, diarrhea, constipation, abdominal pain, headache, and injection site reactions. These typically diminish as dosage is gradually escalated.
Serious side effects may include pancreatitis, gallbladder problems, kidney injury, hypoglycemia (with insulin), and allergic reactions. Consult your healthcare provider immediately if you experience severe symptoms.
Contraindications: History of medullary thyroid carcinoma, MEN 2, pancreatitis, pregnancy or breastfeeding, severe gastrointestinal disease. This is not a complete list — always discuss your full medical history with your physician.
Clinical References:
